Tuesday, November 5, 2024
HomeTagsAPG-5918

APG-5918

Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that its novel...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics